News
23h
MyChesCo on MSNArbutus Biopharma Showcases Promising Results for Hepatitis B Therapies at EASL Congress 2025Arbutus Biopharma Corporation (Nasdaq: ABUS) recently presented compelling data on its investigational hepatitis B therapies, ...
Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...
The Los Angeles County Department of Public Health declared Monday, May 5, a community-wide outbreak of hepatitis A, citing a ...
The Cambridgeshire man's mum had both Hepatitis B and C and her health suffered for many years as a result of it.
TWO toilet related symptoms could be the first signs of a hard-to-spot cancer that’s on the rise in the UK. Bile duct cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results